Ketamine Alters Functional Plasticity of Astroglia: An Implication for Antidepressant Effect
Abstract
:1. Astrocytes, Molecularly Heterogeneous Keepers of the Central Nervous System
2. Astrocytes in Major Depressive Disorder
3. Antidepressants Affect Astrocyte Plasticity
4. Ketamine, the Fastest Antidepressant
5. Ketamine Increases cAMP Activity and Alters Vesicle–Plasmalemma Interaction in Astrocytes
6. Ketamine Attenuates Mobility of Kir4.1 Vesicles and Reduces Surface Density of Kir4.1
7. Ketamine Increases Cholesterol Content in the Exofacial Leaflet of the Astrocyte Plasmalemma
8. Conclusions
Funding
Institutional Review Board Statement
Informed Consent Statement
Acknowledgments
Conflicts of Interest
References
- Verkhratsky, A.; Nedergaard, M. Physiology of Astroglia. Physiol. Rev. 2018, 98, 239–389. [Google Scholar] [CrossRef] [PubMed]
- Verkhratsky, A.; Zorec, R.; Parpura, V. Stratification of astrocytes in healthy and diseased brain. Brain Pathol. 2017, 27, 629–644. [Google Scholar] [CrossRef]
- Azevedo, F.A.; Carvalho, L.R.; Grinberg, L.T.; Farfel, J.M.; Ferretti, R.E.; Leite, R.E.; Jacob Filho, W.; Lent, R.; Herculano-Houzel, S. Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain. J. Comp. Neurol. 2009, 513, 532–541. [Google Scholar] [CrossRef]
- Ben Haim, L.; Rowitch, D.H. Functional diversity of astrocytes in neural circuit regulation. Nat. Rev. Neurosci. 2017, 18, 31–41. [Google Scholar] [CrossRef]
- Herculano-Houzel, S. The glia/neuron ratio: How it varies uniformly across brain structures and species and what that means for brain physiology and evolution. Glia 2014, 62, 1377–1391. [Google Scholar] [CrossRef]
- Khakh, B.S.; Sofroniew, M.V. Diversity of astrocyte functions and phenotypes in neural circuits. Nat. Neurosci. 2015, 18, 942–952. [Google Scholar] [CrossRef] [PubMed]
- Oberheim, N.A.; Goldman, S.A.; Nedergaard, M. Heterogeneity of astrocytic form and function. Methods Mol. Biol. 2012, 814, 23–45. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Verkhratsky, A.; Butt, A.M. The History of the Decline and Fall of the Glial Numbers Legend. Neuroglia 2018, 1, 188–192. [Google Scholar] [CrossRef] [Green Version]
- Verkhratsky, A.; Sofroniew, M.V.; Messing, A.; deLanerolle, N.C.; Rempe, D.; Rodriguez, J.J.; Nedergaard, M. Neurological diseases as primary gliopathies: A reassessment of neurocentrism. ASN Neuro 2012, 4. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Eng, L.F.; Ghirnikar, R.S.; Lee, Y.L. Glial fibrillary acidic protein: GFAP-thirty-one years (1969–2000). Neurochem. Res. 2000, 25, 1439–1451. [Google Scholar] [CrossRef]
- Hol, E.M.; Pekny, M. Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system. Curr. Opin. Cell Biol. 2015, 32, 121–130. [Google Scholar] [CrossRef] [PubMed]
- Gotz, M.; Sirko, S.; Beckers, J.; Irmler, M. Reactive astrocytes as neural stem or progenitor cells: In vivo lineage, In vitro potential, and Genome-wide expression analysis. Glia 2015, 63, 1452–1468. [Google Scholar] [CrossRef]
- Pekny, M. Astrocytic intermediate filaments: Lessons from GFAP and vimentin knock-out mice. Prog. Brain Res. 2001, 132, 23–30. [Google Scholar] [CrossRef]
- Schmidt-Kastner, R.; Szymas, J. Immunohistochemistry of glial fibrillary acidic protein, vimentin and S-100 protein for study of astrocytes in hippocampus of rat. J. Chem. Neuroanat. 1990, 3, 179–192. [Google Scholar]
- Donato, R.; Cannon, B.R.; Sorci, G.; Riuzzi, F.; Hsu, K.; Weber, D.J.; Geczy, C.L. Functions of S100 proteins. Curr. Mol. Med. 2013, 13, 24–57. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ogata, K.; Kosaka, T. Structural and quantitative analysis of astrocytes in the mouse hippocampus. Neuroscience 2002, 113, 221–233. [Google Scholar] [CrossRef]
- Cahoy, J.D.; Emery, B.; Kaushal, A.; Foo, L.C.; Zamanian, J.L.; Christopherson, K.S.; Xing, Y.; Lubischer, J.L.; Krieg, P.A.; Krupenko, S.A.; et al. A transcriptome database for astrocytes, neurons, and oligodendrocytes: A new resource for understanding brain development and function. J. Neurosci. 2008, 28, 264–278. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yang, Y.; Vidensky, S.; Jin, L.; Jie, C.; Lorenzini, I.; Frankl, M.; Rothstein, J.D. Molecular comparison of GLT1+ and ALDH1L1+ astrocytes in vivo in astroglial reporter mice. Glia 2011, 59, 200–207. [Google Scholar] [CrossRef] [Green Version]
- Anlauf, E.; Derouiche, A. Glutamine synthetase as an astrocytic marker: Its cell type and vesicle localization. Front. Endocrinol. 2013, 4, 144. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Derouiche, A.; Frotscher, M. Astroglial processes around identified glutamatergic synapses contain glutamine synthetase: Evidence for transmitter degradation. Brain Res. 1991, 552, 346–350. [Google Scholar] [CrossRef]
- Norenberg, M.D.; Martinez-Hernandez, A. Fine structural localization of glutamine synthetase in astrocytes of rat brain. Brain Res. 1979, 161, 303–310. [Google Scholar] [CrossRef]
- Yeh, C.Y.; Verkhratsky, A.; Terzieva, S.; Rodriguez, J.J. Glutamine synthetase in astrocytes from entorhinal cortex of the triple transgenic animal model of Alzheimer’s disease is not affected by pathological progression. Biogerontology 2013, 14, 777–787. [Google Scholar] [CrossRef] [PubMed]
- Barry, D.; McDermott, K. Differentiation of radial glia from radial precursor cells and transformation into astrocytes in the developing rat spinal cord. Glia 2005, 50, 187–197. [Google Scholar] [CrossRef] [PubMed]
- Jungblut, M.; Tiveron, M.C.; Barral, S.; Abrahamsen, B.; Knobel, S.; Pennartz, S.; Schmitz, J.; Perraut, M.; Pfrieger, F.W.; Stoffel, W.; et al. Isolation and characterization of living primary astroglial cells using the new GLAST-specific monoclonal antibody ACSA-1. Glia 2012, 60, 894–907. [Google Scholar] [CrossRef] [PubMed]
- Schmitt, A.; Asan, E.; Puschel, B.; Kugler, P. Cellular and regional distribution of the glutamate transporter GLAST in the CNS of rats: Nonradioactive in situ hybridization and comparative immunocytochemistry. J. Neurosci. 1997, 17, 1–10. [Google Scholar] [CrossRef] [Green Version]
- Williams, S.M.; Sullivan, R.K.; Scott, H.L.; Finkelstein, D.I.; Colditz, P.B.; Lingwood, B.E.; Dodd, P.R.; Pow, D.V. Glial glutamate transporter expression patterns in brains from multiple mammalian species. Glia 2005, 49, 520–541. [Google Scholar] [CrossRef]
- Nagelhus, E.A.; Mathiisen, T.M.; Ottersen, O.P. Aquaporin-4 in the central nervous system: Cellular and subcellular distribution and coexpression with KIR4.1. Neuroscience 2004, 129, 905–913. [Google Scholar] [CrossRef]
- Nagelhus, E.A.; Ottersen, O.P. Physiological roles of aquaporin-4 in brain. Physiol. Rev. 2013, 93, 1543–1562. [Google Scholar] [CrossRef] [Green Version]
- Dermietzel, R.; Hertberg, E.L.; Kessler, J.A.; Spray, D.C. Gap junctions between cultured astrocytes: Immunocytochemical, molecular, and electrophysiological analysis. J. Neurosci. 1991, 11, 1421–1432. [Google Scholar] [CrossRef] [Green Version]
- Nagy, J.I.; Patel, D.; Ochalski, P.A.; Stelmack, G.L. Connexin30 in rodent, cat and human brain: Selective expression in gray matter astrocytes, co-localization with connexin43 at gap junctions and late developmental appearance. Neuroscience 1999, 88, 447–468. [Google Scholar] [CrossRef]
- Nolte, C.; Matyash, M.; Pivneva, T.; Schipke, C.G.; Ohlemeyer, C.; Hanisch, U.K.; Kirchhoff, F.; Kettenmann, H. GFAP promoter-controlled EGFP-expressing transgenic mice: A tool to visualize astrocytes and astrogliosis in living brain tissue. Glia 2001, 33, 72–86. [Google Scholar] [CrossRef]
- Bushong, E.A.; Martone, M.E.; Jones, Y.Z.; Ellisman, M.H. Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical domains. J. Neurosci. 2002, 22, 183–192. [Google Scholar] [CrossRef] [PubMed]
- Walz, W.; Lang, M.K. Immunocytochemical evidence for a distinct GFAP-negative subpopulation of astrocytes in the adult rat hippocampus. Neurosci. Lett. 1998, 257, 127–130. [Google Scholar] [CrossRef]
- Kettenmann, H.; Verkhratsky, A. Neuroglia—Living Nerve Glue. Fortschr. Neurol. Psychiatr. 2011, 79, 588–597. (In German) [Google Scholar] [CrossRef] [PubMed]
- Heller, J.P.; Rusakov, D.A. Morphological plasticity of astroglia: Understanding synaptic microenvironment. Glia 2015, 63, 2133–2151. [Google Scholar] [CrossRef] [PubMed]
- Kreft, M.; Stenovec, M.; Rupnik, M.; Grilc, S.; Krzan, M.; Potokar, M.; Pangrsic, T.; Haydon, P.G.; Zorec, R. Properties of Ca(2+)-dependent exocytosis in cultured astrocytes. Glia 2004, 46, 437–445. [Google Scholar] [CrossRef]
- Zorec, R.; Araque, A.; Carmignoto, G.; Haydon, P.G.; Verkhratsky, A.; Parpura, V. Astroglial excitability and gliotransmission: An appraisal of Ca2+ as a signalling route. ASN Neuro 2012, 4. [Google Scholar] [CrossRef]
- Araque, A.; Parpura, V.; Sanzgiri, R.P.; Haydon, P.G. Tripartite synapses: Glia, the unacknowledged partner. Trends Neurosci. 1999, 22, 208–215. [Google Scholar] [CrossRef]
- Petrelli, F.; Bezzi, P. Novel insights into gliotransmitters. Curr. Opin. Pharmacol. 2016, 26, 138–145. [Google Scholar] [CrossRef]
- Verkhratsky, A.; Matteoli, M.; Parpura, V.; Mothet, J.P.; Zorec, R. Astrocytes as secretory cells of the central nervous system: Idiosyncrasies of vesicular secretion. EMBO J. 2016, 35, 239–257. [Google Scholar] [CrossRef] [Green Version]
- Rouach, N.; Koulakoff, A.; Abudara, V.; Willecke, K.; Giaume, C. Astroglial metabolic networks sustain hippocampal synaptic transmission. Science 2008, 322, 1551–1555. [Google Scholar] [CrossRef]
- Giaume, C.; Koulakoff, A.; Roux, L.; Holcman, D.; Rouach, N. Astroglial networks: A step further in neuroglial and gliovascular interactions. Nat. Rev. Neurosci. 2010, 11, 87–99. [Google Scholar] [CrossRef]
- Colombo, J.A.; Napp, M.I.; Yanez, A.; Reisin, H. Tissue printing of astroglial interlaminar processes from human and non-human primate cerebral cortex. Brain Res. Bull. 2001, 55, 561–565. [Google Scholar] [CrossRef]
- Oberheim, N.A.; Wang, X.; Goldman, S.; Nedergaard, M. Astrocytic complexity distinguishes the human brain. Trends Neurosci. 2006, 29, 547–553. [Google Scholar] [CrossRef]
- Mathiisen, T.M.; Lehre, K.P.; Danbolt, N.C.; Ottersen, O.P. The perivascular astroglial sheath provides a complete covering of the brain microvessels: An electron microscopic 3D reconstruction. Glia 2010, 58, 1094–1103. [Google Scholar] [CrossRef]
- Abbott, N.J.; Ronnback, L.; Hansson, E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 2006, 7, 41–53. [Google Scholar] [CrossRef]
- Ullian, E.M.; Sapperstein, S.K.; Christopherson, K.S.; Barres, B.A. Control of synapse number by glia. Science 2001, 291, 657–661. [Google Scholar] [CrossRef]
- Seri, B.; Garcia-Verdugo, J.M.; McEwen, B.S.; Alvarez-Buylla, A. Astrocytes give rise to new neurons in the adult mammalian hippocampus. J. Neurosci. 2001, 21, 7153–7160. [Google Scholar] [CrossRef] [Green Version]
- Zorec, R.; Verkhratsky, A.; Rodriguez, J.J.; Parpura, V. Astrocytic vesicles and gliotransmitters: Slowness of vesicular release and synaptobrevin2-laden vesicle nanoarchitecture. Neuroscience 2016, 323, 67–75. [Google Scholar] [CrossRef]
- Clarke, L.E.; Barres, B.A. Emerging roles of astrocytes in neural circuit development. Nat. Rev. Neurosci. 2013, 14, 311–321. [Google Scholar] [CrossRef] [Green Version]
- Zorec, R.; Horvat, A.; Vardjan, N.; Verkhratsky, A. Memory Formation Shaped by Astroglia. Front. Integr. Neurosci. 2015, 9, 56. [Google Scholar] [CrossRef] [Green Version]
- Escartin, C.; Galea, E.; Lakatos, A.; O’Callaghan, J.P.; Petzold, G.C.; Serrano-Pozo, A.; Steinhauser, C.; Volterra, A.; Carmignoto, G.; Agarwal, A.; et al. Reactive astrocyte nomenclature, definitions, and future directions. Nat. Neurosci. 2021, 24, 312–325. [Google Scholar] [CrossRef]
- Burda, J.E.; Sofroniew, M.V. Reactive gliosis and the multicellular response to CNS damage and disease. Neuron 2014, 81, 229–248. [Google Scholar] [CrossRef] [Green Version]
- Pekny, M.; Pekna, M.; Messing, A.; Steinhauser, C.; Lee, J.M.; Parpura, V.; Hol, E.M.; Sofroniew, M.V.; Verkhratsky, A. Astrocytes: A central element in neurological diseases. Acta Neuropathol. 2016, 131, 323–345. [Google Scholar] [CrossRef]
- Trkov Bobnar, S.; Stenovec, M.; Mis, K.; Pirkmajer, S.; Zorec, R. Fingolimod Suppresses the Proinflammatory Status of Interferon-gamma-Activated Cultured Rat Astrocytes. Mol. Neurobiol. 2019, 56, 5971–5986. [Google Scholar] [CrossRef]
- Czeh, B.; Di Benedetto, B. Antidepressants act directly on astrocytes: Evidences and functional consequences. Eur. Neuropsychopharmacol. 2013, 23, 171–185. [Google Scholar] [CrossRef]
- Verkhratsky, A.; Butt, A.M. Glial Physiology and Pathophysiology; Wiley-Blackwell: Chichester, UK, 2013; p. 560. [Google Scholar]
- Zhang, Y.; Barres, B.A. Astrocyte heterogeneity: An underappreciated topic in neurobiology. Curr. Opin. Neurobiol. 2010, 20, 588–594. [Google Scholar] [CrossRef]
- Dietz, A.G.; Goldman, S.A.; Nedergaard, M. Glial cells in schizophrenia: A unified hypothesis. Lancet Psychiatry 2019. [Google Scholar] [CrossRef]
- Peng, L.; Li, B.; Verkhratsky, A. Targeting astrocytes in bipolar disorder. Expert Rev. Neurother. 2016, 16, 649–657. [Google Scholar] [CrossRef] [Green Version]
- Rajkowska, G.; Stockmeier, C.A. Astrocyte pathology in major depressive disorder: Insights from human postmortem brain tissue. Curr. Drug Targets 2013, 14, 1225–1236. [Google Scholar] [CrossRef] [Green Version]
- Verkhratsky, A.; Nedergaard, M. Astroglial cradle in the life of the synapse. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2014, 369, 20130595. [Google Scholar] [CrossRef]
- Verkhratsky, A.; Rodriguez, J.J.; Steardo, L. Astrogliopathology: A central element of neuropsychiatric diseases? Neuroscientist 2014, 20, 576–588. [Google Scholar] [CrossRef] [PubMed]
- Bowley, M.P.; Drevets, W.C.; Ongur, D.; Price, J.L. Low glial numbers in the amygdala in major depressive disorder. Biol. Psychiatry 2002, 52, 404–412. [Google Scholar] [CrossRef]
- Cotter, D.; Mackay, D.; Chana, G.; Beasley, C.; Landau, S.; Everall, I.P. Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb. Cortex 2002, 12, 386–394. [Google Scholar] [CrossRef]
- Cotter, D.; Mackay, D.; Landau, S.; Kerwin, R.; Everall, I. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch. Gen. Psychiatry 2001, 58, 545–553. [Google Scholar] [CrossRef] [Green Version]
- Gittins, R.A.; Harrison, P.J. A morphometric study of glia and neurons in the anterior cingulate cortex in mood disorder. J. Affect. Disord. 2011, 133, 328–332. [Google Scholar] [CrossRef]
- Ongur, D.; Drevets, W.C.; Price, J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc. Natl. Acad. Sci. USA 1998, 95, 13290–13295. [Google Scholar] [CrossRef] [Green Version]
- Rajkowska, G.; Miguel-Hidalgo, J.J.; Wei, J.; Dilley, G.; Pittman, S.D.; Meltzer, H.Y.; Overholser, J.C.; Roth, B.L.; Stockmeier, C.A. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol. Psychiatry 1999, 45, 1085–1098. [Google Scholar] [CrossRef]
- Braun, K.; Antemano, R.; Helmeke, C.; Buchner, M.; Poeggel, G. Juvenile separation stress induces rapid region- and layer-specific changes in S100ss- and glial fibrillary acidic protein-immunoreactivity in astrocytes of the rodent medial prefrontal cortex. Neuroscience 2009, 160, 629–638. [Google Scholar] [CrossRef]
- Czeh, B.; Simon, M.; Schmelting, B.; Hiemke, C.; Fuchs, E. Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment. Neuropsychopharmacology 2006, 31, 1616–1626. [Google Scholar] [CrossRef] [Green Version]
- Barley, K.; Dracheva, S.; Byne, W. Subcortical oligodendrocyte- and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder. Schizophr. Res. 2009, 112, 54–64. [Google Scholar] [CrossRef]
- Bernard, R.; Kerman, I.A.; Thompson, R.C.; Jones, E.G.; Bunney, W.E.; Barchas, J.D.; Schatzberg, A.F.; Myers, R.M.; Akil, H.; Watson, S.J. Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Mol. Psychiatry 2011, 16, 634–646. [Google Scholar] [CrossRef] [Green Version]
- Sequeira, A.; Mamdani, F.; Ernst, C.; Vawter, M.P.; Bunney, W.E.; Lebel, V.; Rehal, S.; Klempan, T.; Gratton, A.; Benkelfat, C.; et al. Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS ONE 2009, 4, e6585. [Google Scholar] [CrossRef]
- Bechtholt-Gompf, A.J.; Walther, H.V.; Adams, M.A.; Carlezon, W.A., Jr.; Ongur, D.; Cohen, B.M. Blockade of astrocytic glutamate uptake in rats induces signs of anhedonia and impaired spatial memory. Neuropsychopharmacology 2010, 35, 2049–2059. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sun, J.D.; Liu, Y.; Yuan, Y.H.; Li, J.; Chen, N.H. Gap junction dysfunction in the prefrontal cortex induces depressive-like behaviors in rats. Neuropsychopharmacology 2012, 37, 1305–1320. [Google Scholar] [CrossRef]
- Holden, C. Excited by Glutamate. Science 2003, 300, 1866–1868. [Google Scholar] [CrossRef]
- Shao, W.; Zhang, S.Z.; Tang, M.; Zhang, X.H.; Zhou, Z.; Yin, Y.Q.; Zhou, Q.B.; Huang, Y.Y.; Liu, Y.J.; Wawrousek, E.; et al. Suppression of neuroinflammation by astrocytic dopamine D2 receptors via alphaB-crystallin. Nature 2013, 494, 90–94. [Google Scholar] [CrossRef]
- Rial, D.; Lemos, C.; Pinheiro, H.; Duarte, J.M.; Goncalves, F.Q.; Real, J.I.; Prediger, R.D.; Goncalves, N.; Gomes, C.A.; Canas, P.M.; et al. Depression as a Glial-Based Synaptic Dysfunction. Front. Cell. Neurosci. 2015, 9, 521. [Google Scholar] [CrossRef] [Green Version]
- Chandley, M.J.; Szebeni, K.; Szebeni, A.; Crawford, J.; Stockmeier, C.A.; Turecki, G.; Miguel-Hidalgo, J.J.; Ordway, G.A. Gene expression deficits in pontine locus coeruleus astrocytes in men with major depressive disorder. J. Psychiatry Neurosci. 2013, 38, 276–284. [Google Scholar] [CrossRef] [Green Version]
- Choudary, P.V.; Molnar, M.; Evans, S.J.; Tomita, H.; Li, J.Z.; Vawter, M.P.; Myers, R.M.; Bunney, W.E., Jr.; Akil, H.; Watson, S.J.; et al. Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc. Natl. Acad. Sci. USA 2005, 102, 15653–15658. [Google Scholar] [CrossRef] [Green Version]
- Medina, A.; Watson, S.J.; Bunney, W., Jr.; Myers, R.M.; Schatzberg, A.; Barchas, J.; Akil, H.; Thompson, R.C. Evidence for alterations of the glial syncytial function in major depressive disorder. J. Psychiatr. Res. 2016, 72, 15–21. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Miguel-Hidalgo, J.J.; Waltzer, R.; Whittom, A.A.; Austin, M.C.; Rajkowska, G.; Stockmeier, C.A. Glial and glutamatergic markers in depression, alcoholism, and their comorbidity. J. Affect. Disord. 2010, 127, 230–240. [Google Scholar] [CrossRef] [Green Version]
- Zhao, J.; Verwer, R.W.; van Wamelen, D.J.; Qi, X.R.; Gao, S.F.; Lucassen, P.J.; Swaab, D.F. Prefrontal changes in the glutamate-glutamine cycle and neuronal/glial glutamate transporters in depression with and without suicide. J. Psychiatr. Res. 2016, 82, 8–15. [Google Scholar] [CrossRef]
- Ordway, G.A.; Szebeni, A.; Chandley, M.J.; Stockmeier, C.A.; Xiang, L.; Newton, S.S.; Turecki, G.; Duffourc, M.M.; Zhu, M.Y.; Zhu, H.; et al. Low gene expression of bone morphogenetic protein 7 in brainstem astrocytes in major depression. Int. J. Neuropsychopharmacol. 2012, 15, 855–868. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Farmer, W.T.; Abrahamsson, T.; Chierzi, S.; Lui, C.; Zaelzer, C.; Jones, E.V.; Bally, B.P.; Chen, G.G.; Theroux, J.F.; Peng, J.; et al. Neurons diversify astrocytes in the adult brain through sonic hedgehog signaling. Science 2016, 351, 849–854. [Google Scholar] [CrossRef] [PubMed]
- Hochstim, C.; Deneen, B.; Lukaszewicz, A.; Zhou, Q.; Anderson, D.J. Identification of positionally distinct astrocyte subtypes whose identities are specified by a homeodomain code. Cell 2008, 133, 510–522. [Google Scholar] [CrossRef] [Green Version]
- Stevens, B.; Muthukumar, A.K. Cellular neuroscience. Differences among astrocytes. Science 2016, 351, 813. [Google Scholar] [CrossRef]
- Tsai, H.H.; Li, H.; Fuentealba, L.C.; Molofsky, A.V.; Taveira-Marques, R.; Zhuang, H.; Tenney, A.; Murnen, A.T.; Fancy, S.P.; Merkle, F.; et al. Regional astrocyte allocation regulates CNS synaptogenesis and repair. Science 2012, 337, 358–362. [Google Scholar] [CrossRef] [Green Version]
- Dong, L.; Li, B.; Verkhratsky, A.; Peng, L. Cell type-specific in vivo expression of genes encoding signalling molecules in the brain in response to chronic mild stress and chronic treatment with fluoxetine. Psychopharmacology 2015, 232, 2827–2835. [Google Scholar] [CrossRef]
- Liu, Z.; Song, D.; Yan, E.; Verkhratsky, A.; Peng, L. Chronic treatment with anti-bipolar drugs suppresses glutamate release from astroglial cultures. Amino Acids 2015, 47, 1045–1051. [Google Scholar] [CrossRef]
- Peng, L.; Song, D.; Li, B.; Verkhratsky, A. Astroglial 5-HT2B receptor in mood disorders. Expert Rev. Neurother. 2018, 18, 435–442. [Google Scholar] [CrossRef]
- Rivera, A.D.; Butt, A.M. Astrocytes are direct cellular targets of lithium treatment: Novel roles for lysyl oxidase and peroxisome-proliferator activated receptor-gamma as astroglial targets of lithium. Transl. Psychiatry 2019, 9, 211. [Google Scholar] [CrossRef] [Green Version]
- Zhang, S.; Li, B.; Lovatt, D.; Xu, J.; Song, D.; Goldman, S.A.; Nedergaard, M.; Hertz, L.; Peng, L. 5-HT2B receptors are expressed on astrocytes from brain and in culture and are a chronic target for all five conventional ‘serotonin-specific reuptake inhibitors’. Neuron Glia Biol. 2010, 6, 113–125. [Google Scholar] [CrossRef]
- Schipke, C.G.; Heuser, I.; Peters, O. Antidepressants act on glial cells: SSRIs and serotonin elicit astrocyte calcium signaling in the mouse prefrontal cortex. J. Psychiatr. Res. 2011, 45, 242–248. [Google Scholar] [CrossRef] [PubMed]
- Hertz, L.; Li, B.; Song, D.; Ren, J.; Dong, L.; Chen, Y.; Peng, L. Astrocytes as a 5-HT2B-mediated SERT-independent SSRI target, slowly altering depression-associated genes and function. Curr. Signal Transduct. Ther. 2012, 7, 16. [Google Scholar] [CrossRef]
- Hertz, L.; Rothman, D.L.; Li, B.; Peng, L. Chronic SSRI stimulation of astrocytic 5-HT2B receptors change multiple gene expressions/editings and metabolism of glutamate, glucose and glycogen: A potential paradigm shift. Front. Behav. Neurosci. 2015, 9, 25. [Google Scholar] [CrossRef] [Green Version]
- Ren, J.; Song, D.; Bai, Q.; Verkhratsky, A.; Peng, L. Fluoxetine induces alkalinization of astroglial cytosol through stimulation of sodium-hydrogen exchanger 1: Dissection of intracellular signaling pathways. Front. Cell. Neurosci. 2015, 9, 61. [Google Scholar] [CrossRef] [Green Version]
- Iwata, M.; Shirayama, Y.; Ishida, H.; Hazama, G.I.; Nakagome, K. Hippocampal astrocytes are necessary for antidepressant treatment of learned helplessness rats. Hippocampus 2011, 21, 877–884. [Google Scholar] [CrossRef] [PubMed]
- Fujiki, M.; Steward, O. High frequency transcranial magnetic stimulation mimics the effects of ECS in upregulating astroglial gene expression in the murine CNS. Brain. Res. Mol. Brain Res. 1997, 44, 301–308. [Google Scholar] [CrossRef]
- Kragh, J.; Bolwig, T.G.; Woldbye, D.P.; Jorgensen, O.S. Electroconvulsive shock and lidocaine-induced seizures in the rat activate astrocytes as measured by glial fibrillary acidic protein. Biol. Psychiatry 1993, 33, 794–800. [Google Scholar] [CrossRef]
- Li, M.; Yao, X.; Sun, L.; Zhao, L.; Xu, W.; Zhao, H.; Zhao, F.; Zou, X.; Cheng, Z.; Li, B.; et al. Effects of Electroconvulsive Therapy on Depression and Its Potential Mechanism. Front. Psychol. 2020, 11, 80. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Monai, H.; Ohkura, M.; Tanaka, M.; Oe, Y.; Konno, A.; Hirai, H.; Mikoshiba, K.; Itohara, S.; Nakai, J.; Iwai, Y.; et al. Calcium imaging reveals glial involvement in transcranial direct current stimulation-induced plasticity in mouse brain. Nat. Commun. 2016, 7, 11100. [Google Scholar] [CrossRef] [PubMed]
- Kohrs, R.; Durieux, M.E. Ketamine: Teaching an old drug new tricks. Anesth. Analg. 1998, 87, 1186–1193. [Google Scholar] [CrossRef]
- Mion, G.; Villevieille, T. Ketamine pharmacology: An update (pharmacodynamics and molecular aspects, recent findings). CNS Neurosci. Ther. 2013, 19, 370–380. [Google Scholar] [CrossRef]
- Domino, E.F. Taming the ketamine tiger. 1965. Anesthesiology 2010, 113, 678–684. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zanos, P.; Moaddel, R.; Morris, P.J.; Riggs, L.M.; Highland, J.N.; Georgiou, P.; Pereira, E.F.R.; Albuquerque, E.X.; Thomas, C.J.; Zarate, C.A., Jr.; et al. Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms. Pharmacol. Rev. 2018, 70, 621–660. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hirota, K.; Okawa, H.; Appadu, B.L.; Grandy, D.K.; Devi, L.A.; Lambert, D.G. Stereoselective interaction of ketamine with recombinant mu, kappa, and delta opioid receptors expressed in Chinese hamster ovary cells. Anesthesiology 1999, 90, 174–182. [Google Scholar] [CrossRef]
- Yang, C.; Shirayama, Y.; Zhang, J.C.; Ren, Q.; Yao, W.; Ma, M.; Dong, C.; Hashimoto, K. R-ketamine: A rapid-onset and sustained antidepressant without psychotomimetic side effects. Transl. Psychiatry 2015, 5, e632. [Google Scholar] [CrossRef]
- Berman, R.M.; Cappiello, A.; Anand, A.; Oren, D.A.; Heninger, G.R.; Charney, D.S.; Krystal, J.H. Antidepressant effects of ketamine in depressed patients. Biol. Psychiatry 2000, 47, 351–354. [Google Scholar] [CrossRef]
- Zarate, C.A., Jr.; Brutsche, N.; Laje, G.; Luckenbaugh, D.A.; Venkata, S.L.; Ramamoorthy, A.; Moaddel, R.; Wainer, I.W. Relationship of ketamine’s plasma metabolites with response, diagnosis, and side effects in major depression. Biol. Psychiatry 2012, 72, 331–338. [Google Scholar] [CrossRef] [Green Version]
- Loo, C.K.; Galvez, V.; O’Keefe, E.; Mitchell, P.B.; Hadzi-Pavlovic, D.; Leyden, J.; Harper, S.; Somogyi, A.A.; Lai, R.; Weickert, C.S.; et al. Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression. Acta Psychiatr. Scand. 2016, 134, 48–56. [Google Scholar] [CrossRef]
- Canuso, C.M.; Singh, J.B.; Fedgchin, M.; Alphs, L.; Lane, R.; Lim, P.; Pinter, C.; Hough, D.; Sanacora, G.; Manji, H.; et al. Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study. Am. J. Psychiatry 2018, 175, 620–630. [Google Scholar] [CrossRef]
- Daly, E.J.; Singh, J.B.; Fedgchin, M.; Cooper, K.; Lim, P.; Shelton, R.C.; Thase, M.E.; Winokur, A.; Van Nueten, L.; Manji, H.; et al. Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial. JAMA Psychiatry 2018, 75, 139–148. [Google Scholar] [CrossRef]
- Singh, J.B.; Fedgchin, M.; Daly, E.; Xi, L.; Melman, C.; De Bruecker, G.; Tadic, A.; Sienaert, P.; Wiegand, F.; Manji, H.; et al. Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study. Biol. Psychiatry 2016, 80, 424–431. [Google Scholar] [CrossRef] [Green Version]
- Abdallah, C.G.; Sanacora, G.; Duman, R.S.; Krystal, J.H. Ketamine and rapid-acting antidepressants: A window into a new neurobiology for mood disorder therapeutics. Annu. Rev. Med. 2015, 66, 509–523. [Google Scholar] [CrossRef] [Green Version]
- Newport, D.J.; Carpenter, L.L.; McDonald, W.M.; Potash, J.B.; Tohen, M.; Nemeroff, C.B.; The APA Council of Research Task Force on Novel Biomarkers and Treatments. Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression. Am. J. Psychiatry 2015, 172, 950–966. [Google Scholar] [CrossRef] [Green Version]
- Sanacora, G.; Treccani, G.; Popoli, M. Towards a glutamate hypothesis of depression: An emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 2012, 62, 63–77. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Autry, A.E.; Adachi, M.; Nosyreva, E.; Na, E.S.; Los, M.F.; Cheng, P.F.; Kavalali, E.T.; Monteggia, L.M. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 2011, 475, 91–95. [Google Scholar] [CrossRef] [Green Version]
- Li, N.; Lee, B.; Liu, R.J.; Banasr, M.; Dwyer, J.M.; Iwata, M.; Li, X.Y.; Aghajanian, G.; Duman, R.S. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010, 329, 959–964. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chowdhury, G.M.; Behar, K.L.; Cho, W.; Thomas, M.A.; Rothman, D.L.; Sanacora, G. (1)H-[(1)(3)C]-nuclear magnetic resonance spectroscopy measures of ketamine’s effect on amino acid neurotransmitter metabolism. Biol. Psychiatry 2012, 71, 1022–1025. [Google Scholar] [CrossRef] [Green Version]
- Chowdhury, G.M.; Zhang, J.; Thomas, M.; Banasr, M.; Ma, X.; Pittman, B.; Bristow, L.; Schaeffer, E.; Duman, R.S.; Rothman, D.L.; et al. Transiently increased glutamate cycling in rat PFC is associated with rapid onset of antidepressant-like effects. Mol. Psychiatry 2016, 22, 120–126. [Google Scholar] [CrossRef] [Green Version]
- Milak, M.S.; Proper, C.J.; Mulhern, S.T.; Parter, A.L.; Kegeles, L.S.; Ogden, R.T.; Mao, X.; Rodriguez, C.I.; Oquendo, M.A.; Suckow, R.F.; et al. A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder. Mol. Psychiatry 2016, 21, 320–327. [Google Scholar] [CrossRef] [Green Version]
- Zanos, P.; Moaddel, R.; Morris, P.J.; Georgiou, P.; Fischell, J.; Elmer, G.I.; Alkondon, M.; Yuan, P.; Pribut, H.J.; Singh, N.S.; et al. NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature 2016, 533, 481–486. [Google Scholar] [CrossRef] [Green Version]
- Kavalali, E.T.; Monteggia, L.M. How does ketamine elicit a rapid antidepressant response? Curr. Opin. Pharmacol. 2014, 20, 35–39. [Google Scholar] [CrossRef] [Green Version]
- Ardalan, M.; Rafati, A.H.; Nyengaard, J.R.; Wegener, G. Rapid antidepressant effect of ketamine correlates with astroglial plasticity in the hippocampus. Br. J. Pharmacol. 2017, 174, 483–492. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Maeng, S.; Zarate, C.A., Jr.; Du, J.; Schloesser, R.J.; McCammon, J.; Chen, G.; Manji, H.K. Cellular mechanisms underlying the antidepressant effects of ketamine: Role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol. Psychiatry 2008, 63, 349–352. [Google Scholar] [CrossRef] [PubMed]
- Liu, W.X.; Wang, J.; Xie, Z.M.; Xu, N.; Zhang, G.F.; Jia, M.; Zhou, Z.Q.; Hashimoto, K.; Yang, J.J. Regulation of glutamate transporter 1 via BDNF-TrkB signaling plays a role in the anti-apoptotic and antidepressant effects of ketamine in chronic unpredictable stress model of depression. Psychopharmacology (Berl.) 2016, 233, 405–415. [Google Scholar] [CrossRef] [PubMed]
- Gasull-Camos, J.; Tarres-Gatius, M.; Artigas, F.; Castane, A. Glial GLT-1 blockade in infralimbic cortex as a new strategy to evoke rapid antidepressant-like effects in rats. Transl. Psychiatry 2017, 7, e1038. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lasic, E.; Rituper, B.; Jorgacevski, J.; Kreft, M.; Stenovec, M.; Zorec, R. Subanesthetic doses of ketamine stabilize the fusion pore in a narrow flickering state in astrocytes. J. Neurochem. 2016, 138, 909–917. [Google Scholar] [CrossRef] [Green Version]
- Mitterauer, B.J. Ketamine may block NMDA receptors in astrocytes causing a rapid antidepressant effect. Front. Synaptic Neurosci. 2012, 4, 8. [Google Scholar] [CrossRef] [Green Version]
- Stenovec, M.; Lasic, E.; Bozic, M.; Bobnar, S.T.; Stout, R.F., Jr.; Grubisic, V.; Parpura, V.; Zorec, R. Ketamine Inhibits ATP-Evoked Exocytotic Release of Brain-Derived Neurotrophic Factor from Vesicles in Cultured Rat Astrocytes. Mol. Neurobiol. 2016, 53, 6882–6896. [Google Scholar] [CrossRef]
- Thrane, A.S.; Rangroo Thrane, V.; Zeppenfeld, D.; Lou, N.; Xu, Q.; Nagelhus, E.A.; Nedergaard, M. General anesthesia selectively disrupts astrocyte calcium signaling in the awake mouse cortex. Proc. Natl. Acad. Sci. USA 2012, 109, 18974–18979. [Google Scholar] [CrossRef] [Green Version]
- Wray, N.H.; Schappi, J.M.; Singh, H.; Senese, N.B.; Rasenick, M.M. NMDAR-independent, cAMP-dependent antidepressant actions of ketamine. Mol. Psychiatry 2018. [Google Scholar] [CrossRef] [PubMed]
- Koyama, Y.; Ishibashi, T.; Hayata, K.; Baba, A. Endothelins modulate dibutyryl cAMP-induced stellation of cultured astrocytes. Brain Res. 1993, 600, 81–88. [Google Scholar] [CrossRef]
- Schiweck, J.; Eickholt, B.J.; Murk, K. Important Shapeshifter: Mechanisms Allowing Astrocytes to Respond to the Changing Nervous System During Development, Injury and Disease. Front. Cell. Neurosci. 2018, 12, 261. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Won, C.L.; Oh, Y.S. cAMP-induced stellation in primary astrocyte cultures with regional heterogeneity. Brain Res. 2000, 887, 250–258. [Google Scholar] [CrossRef]
- Halassa, M.M.; Fellin, T.; Takano, H.; Dong, J.H.; Haydon, P.G. Synaptic islands defined by the territory of a single astrocyte. J. Neurosci. 2007, 27, 6473–6477. [Google Scholar] [CrossRef] [Green Version]
- Witcher, M.R.; Kirov, S.A.; Harris, K.M. Plasticity of perisynaptic astroglia during synaptogenesis in the mature rat hippocampus. Glia 2007, 55, 13–23. [Google Scholar] [CrossRef]
- Fiacco, T.A.; Agulhon, C.; McCarthy, K.D. Sorting out astrocyte physiology from pharmacology. Annu. Rev. Pharmacol. Toxicol. 2009, 49, 151–174. [Google Scholar] [CrossRef]
- Nimmerjahn, A. Astrocytes going live: Advances and challenges. J. Physiol. 2009, 587, 1639–1647. [Google Scholar] [CrossRef]
- Perea, G.; Navarrete, M.; Araque, A. Tripartite synapses: Astrocytes process and control synaptic information. Trends Neurosci. 2009, 32, 421–431. [Google Scholar] [CrossRef] [PubMed]
- Santello, M.; Volterra, A. Synaptic modulation by astrocytes via Ca2+-dependent glutamate release. Neuroscience 2009, 158, 253–259. [Google Scholar] [CrossRef] [PubMed]
- Theodosis, D.T.; Poulain, D.A.; Oliet, S.H. Activity-dependent structural and functional plasticity of astrocyte-neuron interactions. Physiol. Rev. 2008, 88, 983–1008. [Google Scholar] [CrossRef] [Green Version]
- Pfrieger, F.W. Role of glial cells in the formation and maintenance of synapses. Brain Res. Rev. 2010, 63, 39–46. [Google Scholar] [CrossRef] [PubMed]
- Stenovec, M.; Bozic, M.; Pirnat, S.; Zorec, R. Astroglial Mechanisms of Ketamine Action Include Reduced Mobility of Kir4.1-Carrying Vesicles. Neurochem. Res. 2019. [Google Scholar] [CrossRef] [PubMed]
- Fujita, M.; Richards, E.M.; Niciu, M.J.; Ionescu, D.F.; Zoghbi, S.S.; Hong, J.; Telu, S.; Hines, C.S.; Pike, V.W.; Zarate, C.A.; et al. cAMP signaling in brain is decreased in unmedicated depressed patients and increased by treatment with a selective serotonin reuptake inhibitor. Mol. Psychiatry 2017, 22, 754–759. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Borner, S.; Schwede, F.; Schlipp, A.; Berisha, F.; Calebiro, D.; Lohse, M.J.; Nikolaev, V.O. FRET measurements of intracellular cAMP concentrations and cAMP analog permeability in intact cells. Nat. Protoc. 2011, 6, 427–438. [Google Scholar] [CrossRef]
- Lasic, E.; Lisjak, M.; Horvat, A.; Bozic, M.; Sakanovic, A.; Anderluh, G.; Verkhratsky, A.; Vardjan, N.; Jorgacevski, J.; Stenovec, M.; et al. Astrocyte Specific Remodeling of Plasmalemmal Cholesterol Composition by Ketamine Indicates a New Mechanism of Antidepressant Action. Sci. Rep. 2019, 9, 10957. [Google Scholar] [CrossRef] [Green Version]
- Autry, A.E.; Monteggia, L.M. Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol. Rev. 2012, 64, 238–258. [Google Scholar] [CrossRef] [Green Version]
- Duman, R.S.; Aghajanian, G.K.; Sanacora, G.; Krystal, J.H. Synaptic plasticity and depression: New insights from stress and rapid-acting antidepressants. Nat. Med. 2016, 22, 238–249. [Google Scholar] [CrossRef] [Green Version]
- Jiang, C.; Salton, S.R. The Role of Neurotrophins in Major Depressive Disorder. Transl. Neurosci. 2013, 4, 46–58. [Google Scholar] [CrossRef] [Green Version]
- Bjorkholm, C.; Monteggia, L.M. BDNF—A key transducer of antidepressant effects. Neuropharmacology 2016, 102, 72–79. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hisaoka-Nakashima, K.; Kajitani, N.; Kaneko, M.; Shigetou, T.; Kasai, M.; Matsumoto, C.; Yokoe, T.; Azuma, H.; Takebayashi, M.; Morioka, N.; et al. Amitriptyline induces brain-derived neurotrophic factor (BDNF) mRNA expression through ERK-dependent modulation of multiple BDNF mRNA variants in primary cultured rat cortical astrocytes and microglia. Brain Res. 2016, 1634, 57–67. [Google Scholar] [CrossRef] [PubMed]
- Allaman, I.; Fiumelli, H.; Magistretti, P.J.; Martin, J.L. Fluoxetine regulates the expression of neurotrophic/growth factors and glucose metabolism in astrocytes. Psychopharmacology 2011, 216, 75–84. [Google Scholar] [CrossRef] [Green Version]
- Kittel-Schneider, S.; Kenis, G.; Schek, J.; van den Hove, D.; Prickaerts, J.; Lesch, K.P.; Steinbusch, H.; Reif, A. Expression of monoamine transporters, nitric oxide synthase 3, and neurotrophin genes in antidepressant-stimulated astrocytes. Front. Psychiatry 2012, 3, 33. [Google Scholar] [CrossRef] [Green Version]
- Musazzi, L.; Rimland, J.M.; Ieraci, A.; Racagni, G.; Domenici, E.; Popoli, M. Pharmacological characterization of BDNF promoters I, II and IV reveals that serotonin and norepinephrine input is sufficient for transcription activation. Int. J. Neuropsychopharmacol. 2014, 17, 779–791. [Google Scholar] [CrossRef] [Green Version]
- Takano, K.; Yamasaki, H.; Kawabe, K.; Moriyama, M.; Nakamura, Y. Imipramine induces brain-derived neurotrophic factor mRNA expression in cultured astrocytes. J. Pharmacol. Sci. 2012, 120, 176–186. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Malarkey, E.B.; Ni, Y.; Parpura, V. Ca2+ entry through TRPC1 channels contributes to intracellular Ca2+ dynamics and consequent glutamate release from rat astrocytes. Glia 2008, 56, 821–835. [Google Scholar] [CrossRef]
- Verkhratsky, A.; Rodriguez, J.J.; Parpura, V. Calcium signalling in astroglia. Mol. Cell. Endocrinol. 2012, 353, 45–56. [Google Scholar] [CrossRef]
- Abdelhamid, R.E.; Kovács, K.J.; Nunez, M.G.; Larson, A.A. Depressive behavior in the forced swim test can be induced by TRPV1 receptor activity and is dependent on NMDA receptors. Pharmacol. Res. 2014, 79, 21–27. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bahnasi, Y.M.; Wright, H.M.; Milligan, C.J.; Dedman, A.M.; Zeng, F.; Hopkins, P.M.; Bateson, A.N.; Beech, D.J. Modulation of TRPC5 cation channels by halothane, chloroform and propofol. Br. J. Pharmacol. 2008, 153, 1505–1512. [Google Scholar] [CrossRef] [Green Version]
- Zhang, Y.; Wu, S.; Xie, L.; Yu, S.; Zhang, L.; Liu, C.; Zhou, W.; Yu, T. Ketamine Within Clinically Effective Range Inhibits Glutamate Transmission From Astrocytes to Neurons and Disrupts Synchronization of Astrocytic SICs. Front. Cell. Neurosci. 2019, 13, 240. [Google Scholar] [CrossRef] [PubMed]
- Tassonyi, E.; Charpantier, E.; Muller, D.; Dumont, L.; Bertrand, D. The role of nicotinic acetylcholine receptors in the mechanisms of anesthesia. Brain Res. Bull. 2002, 57, 133–150. [Google Scholar] [CrossRef]
- Kreft, M.; Jorgacevski, J.; Stenovec, M.; Zorec, R. Angstrom-size exocytotic fusion pore: Implications for pituitary hormone secretion. Mol. Cell. Endocrinol. 2018, 463, 65–71. [Google Scholar] [CrossRef] [PubMed]
- Keiser, M.; Hasan, M.; Oswald, S. Affinity of Ketamine to Clinically Relevant Transporters. Mol. Pharm. 2018, 15, 326–331. [Google Scholar] [CrossRef]
- Lester, H.A.; Lavis, L.D.; Dougherty, D.A. Ketamine inside neurons? Am. J. Psychiatry 2015, 172, 1064–1066. [Google Scholar] [CrossRef] [Green Version]
- Kabaso, D.; Calejo, A.I.; Jorgacevski, J.; Kreft, M.; Zorec, R.; Iglic, A. Fusion pore diameter regulation by cations modulating local membrane anisotropy. Sci. World J. 2012, 2012, 983138. [Google Scholar] [CrossRef] [Green Version]
- Jain, M.K.; Jahagirdar, D.V.; Van Linde, M.; Roelofsen, B.; Eibl, H. Solute-induced acceleration of transbilayer movement and its implications on models of blood-brain barrier. Biochim. Biophys. Acta 1985, 818, 356–364. [Google Scholar] [CrossRef]
- Bergami, M.; Santi, S.; Formaggio, E.; Cagnoli, C.; Verderio, C.; Blum, R.; Berninger, B.; Matteoli, M.; Canossa, M. Uptake and recycling of pro-BDNF for transmitter-induced secretion by cortical astrocytes. J. Cell Biol. 2008, 183, 213–221. [Google Scholar] [CrossRef] [PubMed]
- Vignoli, B.; Battistini, G.; Melani, R.; Blum, R.; Santi, S.; Berardi, N.; Canossa, M. Peri-Synaptic Glia Recycles Brain-Derived Neurotrophic Factor for LTP Stabilization and Memory Retention. Neuron 2016, 92, 873–887. [Google Scholar] [CrossRef] [Green Version]
- Cui, Y.; Yang, Y.; Ni, Z.; Dong, Y.; Cai, G.; Foncelle, A.; Ma, S.; Sang, K.; Tang, S.; Li, Y.; et al. Astroglial Kir4.1 in the lateral habenula drives neuronal bursts in depression. Nature 2018, 554, 323–327. [Google Scholar] [CrossRef] [Green Version]
- Yang, Y.; Cui, Y.; Sang, K.; Dong, Y.; Ni, Z.; Ma, S.; Hu, H. Ketamine blocks bursting in the lateral habenula to rapidly relieve depression. Nature 2018, 554, 317–322. [Google Scholar] [CrossRef] [PubMed]
- Breslin, K.; Wade, J.J.; Wong-Lin, K.; Harkin, J.; Flanagan, B.; Van Zalinge, H.; Hall, S.; Walker, M.; Verkhratsky, A.; McDaid, L. Potassium and sodium microdomains in thin astroglial processes: A computational model study. PLoS Comput. Biol. 2018, 14, e1006151. [Google Scholar] [CrossRef]
- Nwaobi, S.E.; Cuddapah, V.A.; Patterson, K.C.; Randolph, A.C.; Olsen, M.L. The role of glial-specific Kir4.1 in normal and pathological states of the CNS. Acta Neuropathol. 2016, 132, 1–21. [Google Scholar] [CrossRef]
- Furutani, K.; Ohno, Y.; Inanobe, A.; Hibino, H.; Kurachi, Y. Mutational and in silico analyses for antidepressant block of astroglial inward-rectifier Kir4.1 channel. Mol. Pharmacol. 2009, 75, 1287–1295. [Google Scholar] [CrossRef] [Green Version]
- Ohno, Y.; Hibino, H.; Lossin, C.; Inanobe, A.; Kurachi, Y. Inhibition of astroglial Kir4.1 channels by selective serotonin reuptake inhibitors. Brain Res. 2007, 1178, 44–51. [Google Scholar] [CrossRef]
- Su, S.; Ohno, Y.; Lossin, C.; Hibino, H.; Inanobe, A.; Kurachi, Y. Inhibition of astroglial inwardly rectifying Kir4.1 channels by a tricyclic antidepressant, nortriptyline. J. Pharmacol. Exp. Ther. 2007, 320, 573–580. [Google Scholar] [CrossRef] [PubMed]
- Soldati, T.; Schliwa, M. Powering membrane traffic in endocytosis and recycling. Nat. Rev. Mol. Cell Biol. 2006, 7, 897–908. [Google Scholar] [CrossRef] [PubMed]
- Bensel, B.M.; Guzik-Lendrum, S.; Masucci, E.M.; Woll, K.A.; Eckenhoff, R.G.; Gilbert, S.P. Common general anesthetic propofol impairs kinesin processivity. Proc. Natl. Acad. Sci. USA 2017, 114, E4281–E4287. [Google Scholar] [CrossRef] [Green Version]
- Nagler, K.; Mauch, D.H.; Pfrieger, F.W. Glia-derived signals induce synapse formation in neurons of the rat central nervous system. J. Physiol. 2001, 533, 665–679. [Google Scholar] [CrossRef]
- Pfrieger, F.W.; Barres, B.A. Synaptic efficacy enhanced by glial cells in vitro. Science 1997, 277, 1684–1687. [Google Scholar] [CrossRef] [Green Version]
- Mauch, D.H.; Nagler, K.; Schumacher, S.; Goritz, C.; Muller, E.C.; Otto, A.; Pfrieger, F.W. CNS synaptogenesis promoted by glia-derived cholesterol. Science 2001, 294, 1354–1357. [Google Scholar] [CrossRef]
- Dietschy, J.M.; Turley, S.D. Cholesterol metabolism in the brain. Curr. Opin. Lipidol. 2001, 12, 105–112. [Google Scholar] [CrossRef] [PubMed]
- Goritz, C.; Mauch, D.H.; Pfrieger, F.W. Multiple mechanisms mediate cholesterol-induced synaptogenesis in a CNS neuron. Mol. Cell. Neurosci. 2005, 29, 190–201. [Google Scholar] [CrossRef] [PubMed]
- Pfenninger, K.H. Plasma membrane expansion: A neuron’s Herculean task. Nat. Rev. Neurosci. 2009, 10, 251–261. [Google Scholar] [CrossRef] [PubMed]
- Hama, H.; Hara, C.; Yamaguchi, K.; Miyawaki, A. PKC signaling mediates global enhancement of excitatory synaptogenesis in neurons triggered by local contact with astrocytes. Neuron 2004, 41, 405–415. [Google Scholar] [CrossRef] [Green Version]
- Peng, H.B.; Yang, J.F.; Dai, Z.; Lee, C.W.; Hung, H.W.; Feng, Z.H.; Ko, C.P. Differential effects of neurotrophins and schwann cell-derived signals on neuronal survival/growth and synaptogenesis. J. Neurosci. 2003, 23, 5050–5060. [Google Scholar] [CrossRef]
- Liu, S.L.; Sheng, R.; Jung, J.H.; Wang, L.; Stec, E.; O’Connor, M.J.; Song, S.; Bikkavilli, R.K.; Winn, R.A.; Lee, D.; et al. Orthogonal lipid sensors identify transbilayer asymmetry of plasma membrane cholesterol. Nat. Chem. Biol. 2017, 13, 268–274. [Google Scholar] [CrossRef] [Green Version]
- Ohno-Iwashita, Y.; Iwamoto, M.; Ando, S.; Mitsui, K.; Iwashita, S. A modified theta-toxin produced by limited proteolysis and methylation: A probe for the functional study of membrane cholesterol. Biochim. Biophys. Acta 1990, 1023, 441–448. [Google Scholar] [CrossRef]
- Radley, J.J.; Rocher, A.B.; Miller, M.; Janssen, W.G.; Liston, C.; Hof, P.R.; McEwen, B.S.; Morrison, J.H. Repeated stress induces dendritic spine loss in the rat medial prefrontal cortex. Cereb. Cortex 2006, 16, 313–320. [Google Scholar] [CrossRef]
- Kang, H.J.; Voleti, B.; Hajszan, T.; Rajkowska, G.; Stockmeier, C.A.; Licznerski, P.; Lepack, A.; Majik, M.S.; Jeong, L.S.; Banasr, M.; et al. Decreased expression of synapse-related genes and loss of synapses in major depressive disorder. Nat. Med. 2012, 18, 1413–1417. [Google Scholar] [CrossRef]
- Kritchevsky, D.; Tepper, S.A.; Davidson, L.M.; Story, J.A. Influence of ketamine, phenylcyclidine, and phenobarbital on cholesterol metabolism in rats. Proc. Soc. Exp. Biol. Med. 1976, 151, 445–447. [Google Scholar] [CrossRef] [PubMed]
- Saranteas, T.; Zotos, N.; Lolis, E.; Stranomiti, J.; Mourouzis, C.; Chantzi, C.; Tesseromatis, C. Mechanisms of ketamine action on lipid metabolism in rats. Eur. J. Anaesthesiol. 2005, 22, 222–226. [Google Scholar] [CrossRef] [PubMed]
- Zanos, P.; Gould, T.D. Mechanisms of ketamine action as an antidepressant. Mol. Psychiatry 2018, 23, 801–811. [Google Scholar] [CrossRef]
- Stenovec, M.; Li, B.; Verkhratsky, A.; Zorec, R. Astrocytes in rapid ketamine antidepressant action. Neuropharmacology 2020, 173, 108158. [Google Scholar] [CrossRef] [PubMed]
- Zarate, C.A., Jr.; Singh, J.B.; Carlson, P.J.; Brutsche, N.E.; Ameli, R.; Luckenbaugh, D.A.; Charney, D.S.; Manji, H.K. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch. Gen. Psychiatry 2006, 63, 856–864. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Stenovec, M. Ketamine Alters Functional Plasticity of Astroglia: An Implication for Antidepressant Effect. Life 2021, 11, 573. https://doi.org/10.3390/life11060573
Stenovec M. Ketamine Alters Functional Plasticity of Astroglia: An Implication for Antidepressant Effect. Life. 2021; 11(6):573. https://doi.org/10.3390/life11060573
Chicago/Turabian StyleStenovec, Matjaž. 2021. "Ketamine Alters Functional Plasticity of Astroglia: An Implication for Antidepressant Effect" Life 11, no. 6: 573. https://doi.org/10.3390/life11060573